GlucaGen

GlucaGen is a brand name of glucagon, approved by the FDA in the following formulation(s):

GLUCAGEN (glucagon hydrochloride recombinant - injectable; injection)

• 
  Manufacturer: NOVO NORDISK
  
  Approval date: June 22, 1998
  
  Strength(s): EQ 1MG BASE/VIAL ^[RLD]

Has a generic version of GlucaGen been approved?

No. There is currently no therapeutically equivalent version of GlucaGen available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of GlucaGen. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with GlucaGen.

See also...

• GlucaGen Consumer Information (Wolters Kluwer)
• GlucaGen Consumer Information (Cerner Multum)
• Glucagen Advanced Consumer Information (Micromedex)
• Glucagen Diagnostic Kit Advanced Consumer Information (Micromedex)
• GlucaGen AHFS DI Monographs (ASHP)
• Glucagon Consumer Information (Wolters Kluwer)
• Glucagon Consumer Information (Cerner Multum)
• Glucagon Diagnostic Kit Advanced Consumer Information (Micromedex)
• Glucagon Emergency Kit Advanced Consumer Information (Micromedex)
• Glucagon Injection Advanced Consumer Information (Micromedex)
• Glucagon AHFS DI Monographs (ASHP)